Delivery Order SPE2DB20D6037-SPE2DB25FTTW3
Award Date
11/1/24
Potential Completion Date
11/4/24
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $31,745.75 contract, which has no set-aside designation, is for the delivery of Activase 100 mg vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $16,847.06, is for the delivery of the pharmaceutical product Activase 100 mg vials. It is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,594.91, is for the delivery of ACTIVASE 50 MG VIALS and has an ultimate completion date of April 5, 2024. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a potential value of up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,047.45 firm fixed-price contract is for the supply of ACTIVASE 100 MG VIALS, a pharmaceutical product, with a period of performance through September 3, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,183.23 order is for 50 mg vials of the medication Activase, with a period of performance through July 15, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,253.96, is for the delivery of Activase 50 mg vials. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $25,396.60, is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA) under the DLA's Medical Supply Chain program. The contract is for the delivery of Activase 100 mg vials, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $50,793.20 firm fixed-price delivery order is for the supply of 4565677111 ACTIVASE 100 MG VIALS, with an ultimate completion date of August 29, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Activase 100 mg vials. The order, valued at $14,015.45, is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a wide range of pharmaceutical items to support the medical supply needs of...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract, valued at $9,549.69, is for the delivery of 50 mg vials of the medication ACTIVASE. This is a recurring medical supply contract to support the needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA...